| Literature DB >> 23966619 |
Christine Nießner1, Susanne Denzau, Katrin Stapput, Margaret Ahmad, Leo Peichl, Wolfgang Wiltschko, Roswitha Wiltschko.
Abstract
The radical pair model proposes that the avian magnetic compass is based on radical pair processes in the eye, with cryptochrome, a flavoprotein, suggested as receptor molecule. Cryptochrome 1a (Cry1a) is localized at the discs of the outer segments of the UV/violet cones of European robins and chickens. Here, we show the activation characteristics of a bird cryptochrome in vivo under natural conditions. We exposed chickens for 30 min to different light regimes and analysed the amount of Cry1a labelled with an antiserum against an epitope at the C-terminus of this protein. The staining after exposure to sunlight and to darkness indicated that the antiserum labels only an illuminated, activated form of Cry1a. Exposure to narrow-bandwidth lights of various wavelengths revealed activated Cry1a at UV, blue and turquoise light. With green and yellow, the amount of activated Cry1a was reduced, and with red, as in the dark, no activated Cry1a was labelled. Activated Cry1a is thus found at all those wavelengths at which birds can orient using their magnetic inclination compass, supporting the role of Cry1a as receptor molecule. The observation that activated Cry1a and well-oriented behaviour occur at 565 nm green light, a wavelength not absorbed by the fully oxidized form of cryptochrome, suggests that a state other than the previously suggested Trp/FAD radical pair formed during photoreduction is crucial for detecting magnetic directions.Entities:
Keywords: conformational change; cryptochrome 1a; flavin cycle; magnetic compass; photoreceptor
Mesh:
Substances:
Year: 2013 PMID: 23966619 PMCID: PMC3785833 DOI: 10.1098/rsif.2013.0638
Source DB: PubMed Journal: J R Soc Interface ISSN: 1742-5662 Impact factor: 4.118
Parameters of exposure to light and number of birds involved. Peak (qu1, qu3), peak wavelength and wavelengths with half the intensity; N, number of chickens; abbreviations used in the figures.
| pre-treatment | light treatment | wavelength (nm) peak (qu1, qu3) | intensity (mW m−2) | duration (min) | abbreviation | |
|---|---|---|---|---|---|---|
| daylight | darkness | — | 30 | 3 | D | |
| daylight | sunlight | full spectrum | 30 | 3 | S | |
| darknessa | UV | 373 (368, 381) | 0.3 | 5 | 2 | D–UV |
| daylight | UV | 373 (368, 381) | 0.3 | 30 | 3 | UV |
| daylight | blue | 424 (403, 459) | 2.4 | 30 | 2 | B |
| daylight | turquoise | 502 (486, 518) | 2.1 | 30 | 3 | T |
| daylight | green | 565 (550, 583) | 1.9 | 30 | 4 | G |
| daylight | yellow | 590 (571, 604) | 1.8 | 30 | 2 | Y |
| daylight | red | 645 (625, 666) | 1.7 | 30 | 3 | R |
aThis pre-treatment in darkness lasted 30 min.
Figure 1.Double immunofluorescence labelling of chicken retinae for violet opsin marking the violet cones ((i) magenta fluorescence) and for Cry1a ((ii) green fluorescence). The two images in each row show the two labels in the same patch of retina. Treatment of the chickens: (a) pre-treatment in daylight, 30 min in sunlight (S); (b) pre-treatment in daylight, 30 min in total darkness (D); (c) 30 min pre-treatment in darkness, 5 min in 373 nm UV light (D–UV). The scale bar represents 50 µm (applies to all panels).
Figure 2.Amount of Cry1a immunolabelled with an antiserum against an epitope near the C-terminus of Cry1a after exposure to narrow-bandwidth lights of different wavelengths. UV, 373 nm ultraviolet; B, 424 nm blue; T, 502 nm turquoise; G, 565 nm green; Y, 590 nm yellow; R, 645 nm red (control labelling of these fields with the antiserum against violet opsin is shown in the electronic supplementary material, figure S1). The scale bar represents 50 µm (applies to all panels).
Figure 3.Flavin cycle of cryptochrome indicating where our antiserum (AS) might bind. Nt, nitrogen-terminus; Ct, carboxy-terminus of the protein, with the antiserum-binding epitope in red; in parentheses, radical pairs. Black arrows indicate light-independent reactions.